JANUMET XR 50 mg/1

Janumet XR 50 mg/1 combines sitagliptin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes.

Janumet XR 50 mg/1 is primarily used to improve glycemic control in adults with type 2 diabetes. This extended-release tablet combines sitagliptin, a DPP-4 inhibitor, and metformin hydrochloride, a biguanide. Together, they work to lower blood sugar levels by enhancing insulin sensitivity and reducing glucose production. People often ask, 'What is Janumet XR used for?' It is typically prescribed as part of a comprehensive diabetes management plan, including diet and exercise.

Common effects of Janumet XR 50 mg/1 may include gastrointestinal discomfort, such as nausea, diarrhea, or abdominal pain. Some users also report headache or upper respiratory tract infection. These effects vary by individual and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Janumet XR 50 mg/1 should be handled with care, especially for those with kidney or liver issues. It is important to stay hydrated and monitor blood sugar levels regularly. Avoid alcohol while taking this medication, as it may increase the risk of lactic acidosis. Always follow the guidance of a healthcare professional.

Janumet XR 50 mg/1 may interact with certain medications, including diuretics, corticosteroids, and some antibiotics. Alcohol can also increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions. CYP inhibitors and inducers may affect how this medication works.